Exane Derivatives’s AB InBev BUD Stock Holding History

Exane Derivatives’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-60	Closed	-$60.8K	–	931
2020 Q4	$60.8K	Hold	60	–	–	0.02%	445
2020 Q3	$158K	Hold	60	–	–	0.05%	234
2020 Q2	$189K	Hold	60	–	–	0.05%	217
2020 Q1	$226K	Sell	60 -502	-89%	-$32.8K	0.06%	184
2019 Q4	$107K	Sell	562 -391	-41%	-$32.6K	0.02%	311
2019 Q3	$92.1K	Buy	953 +383	+67%	+$36.3K	0.02%	323
2019 Q2	$125K	Sell	570 -48	-8%	-$4.12K	0.02%	305
2019 Q1	$111K	Buy	618 +420	+212%	+$32.3K	0.02%	286
2018 Q4	$726K	Sell	198 -517	-72%	-$39.6K	0.13%	146
2018 Q3	$729K	Buy	715 +30	+4%	+$2.92K	0.14%	135
2018 Q2	$381K	Buy	685 +385	+128%	+$38.2K	0.06%	197
2018 Q1	$33.3K	Sell	300 -50	-14%	-$5.54K	0.01%	371
2017 Q4	$191K	Sell	350 -355	-50%	-$41.8K	0.03%	243
2017 Q3	$553K	Buy	705 +452	+179%	+$52.9K	0.1%	130
2017 Q2	$48K	Buy	+253	New	+$29K	0.01%	320
2017 Q1	–	Sell	-947	Closed	-$932K	–	588
2016 Q4	$932K	Sell	947 -232	-20%	-$26K	0.18%	92
2016 Q3	$314K	Buy	+1,179	New	+$149K	0.05%	179
2016 Q2	–	Sell	-873	Closed	-$504K	–	563
2016 Q1	$504K	Buy	873 +585	+203%	+$69.4K	0.07%	135
2015 Q4	$394K	Buy	+288	New	+$34.9K	0.05%	132

Other funds holding BUD

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BCF

BLS Capital Fondsmaeglerselskab Klampenborg, Denmark $2.94B AUM 13.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Exane Derivatives's BUD Position: Q2 2022 in Review

Exane Derivatives held its AB InBev (BUD) position steady in Q2 2022 at 6 shares worth $324. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Exane Derivatives first reported a position in BUD in Q3 2015 and has held it in 23 quarters since. The position peaked at $11.3M in Q4 2016. 513 funds tracked by Wall St. Rank hold BUD as of Q2 2022.

Exane Derivatives held 6 shares of AB InBev worth $324 as of Q2 2022.
Exane Derivatives left its AB InBev share count unchanged in Q2 2022.
AB InBev made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #626 holding.
Exane Derivatives first reported a position in AB InBev in Q3 2015 and has held it in 23 quarters since.
Exane Derivatives's AB InBev position peaked at $11.3M in Q4 2016.
513 funds tracked by Wall St. Rank held AB InBev as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.